{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:cobel-darou-company",
    "identifier": "hg:company:cobel-darou-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Cobel Darou Company",
    "slug": "cobel-darou-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/cobel-darou-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/cobel-darou-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/cobel-darou-company",
    "summary": "",
    "machine_summary": "Cobel Darou Company Cobel Darou Company is a private Tehran-based pharmaceutical group active in importing, registering, marketing, and distributing specialty and general medicines. In the Hormuz Group company graph, it matters because it connects foreign pharmaceutical suppliers, Iranian regulatory approval, specialty-drug access, hospital channels, and domestic distribution. Its role is especially relevant in therapeutic areas where import dependence, payment limitations, and continuity of supply can affect patient access and healthcare-sector resilience. Cobel Darou is relevant for investors assessing Iran's specialty-pharmaceutical market, import channels, regulatory registration, distribution depth, and healthcare counterparty risk. It can support analysis of access to oncology, diabetes, cardiovascular, radiology, and other high-priority medicines under sanctions and payment constraints. Due diligence should verify current legal structure, exact website and group entities, product registrations, international supplier relationships, distribution subsidiary exposure, medical-device activity, compliance history, and dependency on regulated import approvals. Cobel Darou Company operates in pharmaceutical import, registration, marketing, distribution, and selected manufacturing or localization activity, with focus on specialty and general medicines including oncology, cardiovascular, diabetes, radiology, respiratory, gastrointestinal, renal, antimicrobial, neurological, pain-management, vaccine, and medical-product categories. province: Tehran industry: Healthcare & Pharma, Medical Devices, Pharmaceuticals market: Consumer Demand, Healthcare, Imports, Supply Chains challenges: Compliance, Import Dependence, Money Transfer, Supply Shortage company_type: Distributor, Importer, Private Company city: Tehran",
    "published_at": "2026-06-28T20:21:35+00:00",
    "modified_at": "2026-06-28T20:21:35+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 122,
                "name": "Medical Devices",
                "slug": "medical-devices",
                "url": "https://hormuz.group/industry/healthcare-pharma/medical-devices/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 57,
                "name": "Imports",
                "slug": "imports",
                "url": "https://hormuz.group/market/trade-transit/imports/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 160,
                "name": "Money Transfer",
                "slug": "money-transfer",
                "url": "https://hormuz.group/challenges/financial-barriers/money-transfer/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            }
        ],
        "company_type": [
            {
                "id": 302,
                "name": "Distributor",
                "slug": "distributor",
                "url": "https://hormuz.group/company-type/distributor/"
            },
            {
                "id": 301,
                "name": "Importer",
                "slug": "importer",
                "url": "https://hormuz.group/company-type/importer/"
            },
            {
                "id": 307,
                "name": "Private Company",
                "slug": "private-company",
                "url": "https://hormuz.group/company-type/private-company/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Medical Devices, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Imports, Supply Chains",
        "challenges": "Compliance, Import Dependence, Money Transfer, Supply Shortage",
        "company_type": "Distributor, Importer, Private Company",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Cobel Darou Company",
        "website": "https://cobelgroup.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "listing_status": "private",
        "products_services": "Cobel Darou Company operates in pharmaceutical import, registration, marketing, distribution, and selected manufacturing or localization activity, with focus on specialty and general medicines including oncology, cardiovascular, diabetes, radiology, respiratory, gastrointestinal, renal, antimicrobial, neurological, pain-management, vaccine, and medical-product categories.",
        "export_relevance": "none",
        "short_profile": "Cobel Darou Company is a private Tehran-based pharmaceutical group active in importing, registering, marketing, and distributing specialty and general medicines. In the Hormuz Group company graph, it matters because it connects foreign pharmaceutical suppliers, Iranian regulatory approval, specialty-drug access, hospital channels, and domestic distribution. Its role is especially relevant in therapeutic areas where import dependence, payment limitations, and continuity of supply can affect patient access and healthcare-sector resilience.",
        "investment_relevance": "Cobel Darou is relevant for investors assessing Iran's specialty-pharmaceutical market, import channels, regulatory registration, distribution depth, and healthcare counterparty risk. It can support analysis of access to oncology, diabetes, cardiovascular, radiology, and other high-priority medicines under sanctions and payment constraints. Due diligence should verify current legal structure, exact website and group entities, product registrations, international supplier relationships, distribution subsidiary exposure, medical-device activity, compliance history, and dependency on regulated import approvals."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Cobel Darou Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "export_relevance": "none",
        "verification_status": "basic",
        "data_confidence": "medium",
        "listing_status": "private",
        "last_updated": "28/06/2026",
        "website": "https://cobelgroup.com",
        "products_services": "Cobel Darou Company operates in pharmaceutical import, registration, marketing, distribution, and selected manufacturing or localization activity, with focus on specialty and general medicines including oncology, cardiovascular, diabetes, radiology, respiratory, gastrointestinal, renal, antimicrobial, neurological, pain-management, vaccine, and medical-product categories.",
        "short_profile": "Cobel Darou Company is a private Tehran-based pharmaceutical group active in importing, registering, marketing, and distributing specialty and general medicines. In the Hormuz Group company graph, it matters because it connects foreign pharmaceutical suppliers, Iranian regulatory approval, specialty-drug access, hospital channels, and domestic distribution. Its role is especially relevant in therapeutic areas where import dependence, payment limitations, and continuity of supply can affect patient access and healthcare-sector resilience.",
        "investment_relevance": "Cobel Darou is relevant for investors assessing Iran's specialty-pharmaceutical market, import channels, regulatory registration, distribution depth, and healthcare counterparty risk. It can support analysis of access to oncology, diabetes, cardiovascular, radiology, and other high-priority medicines under sanctions and payment constraints. Due diligence should verify current legal structure, exact website and group entities, product registrations, international supplier relationships, distribution subsidiary exposure, medical-device activity, compliance history, and dependency on regulated import approvals.",
        "source_note": "Based on public company, healthcare-sector, pharmaceutical-import, distribution, market, and registry-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 19
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 7
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 22
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 374
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 543
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 615
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 221
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, healthcare-sector, pharmaceutical-import, distribution, market, and registry-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "medium",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "medium",
        "last_updated": "28/06/2026"
    }
}